Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
The International Journal of Cardiovascular Imaging
|
November 9, 2021
The diagnostic accuracy of truncated cardiovascular MR protocols for detecting non-ischemic cardiomyopathies
K Hirschberg, Sz M Braun, O Paul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
L R Yates, J Seoane, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 13, 2007
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers
C Mazouni, S-W Kau, D Frye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2019
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
R Condorelli, F Mosele, B Verret, et al.
Clinical Radiology
|
April 12, 2017
Strengths and limitations of coronary angiography with turbo high-pitch third-generation dual-source CT
M M Ochs, F Andre, G Korosoglou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2020
Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors"
J-C Soria, F DeBraud, R Bahleda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2014
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
J-C Soria, F DeBraud, R Bahleda, et al.
ESMO Open
|
October 24, 2021
Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM database
A Bassompierre, S Dalac, B Dreno, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 31, 2012
Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer
M Arnedos, V Scott, B Job, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2022
Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification
D Trapani, M A Franzoi, H J Burstein, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
The International Journal of Cardiovascular Imaging
|
November 9, 2021
The diagnostic accuracy of truncated cardiovascular MR protocols for detecting non-ischemic cardiomyopathies
K Hirschberg, Sz M Braun, O Paul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
L R Yates, J Seoane, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 13, 2007
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers
C Mazouni, S-W Kau, D Frye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2019
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
R Condorelli, F Mosele, B Verret, et al.
Clinical Radiology
|
April 12, 2017
Strengths and limitations of coronary angiography with turbo high-pitch third-generation dual-source CT
M M Ochs, F Andre, G Korosoglou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2020
Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors"
J-C Soria, F DeBraud, R Bahleda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2014
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
J-C Soria, F DeBraud, R Bahleda, et al.
ESMO Open
|
October 24, 2021
Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM database
A Bassompierre, S Dalac, B Dreno, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 31, 2012
Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer
M Arnedos, V Scott, B Job, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2022
Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification
D Trapani, M A Franzoi, H J Burstein, et al.
Page
of 12